Xtant Medical Holdings Inc. logo

Xtant Medical Holdings Inc. (XMS)

Market Closed
3 Jul, 06:01
XMUN XMUN
0. 60
-0.02
-3.25%
- Market Cap
90.45 P/E Ratio
0% Div Yield
0 Volume
-0.06 Eps
0.62
Previous Close
Day Range
0.6 0.6
Year Range
0.35 0.69
Want to track XMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 25 days

Summary

XMS closed Thursday lower at €0.6, a decrease of 3.25% from Wednesday's close, completing a monthly decrease of -3.25% or €0.02. Over the past 12 months, XMS stock gained 39.02%.
XMS is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2025, exceeded the consensus estimates by 0.02%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 31, 2025.
Xtant Medical Holdings Inc. has completed 1 stock splits, with the recent split occurring on Feb 14, 2018.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on AMEX (USD).

XMS Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Xtant Medical Announces the Launch of OsteoFactor Pro™

Xtant Medical Announces the Launch of OsteoFactor Pro™

Allogeneic Growth Factor Solution to Accelerate Bone Repair BELGRADE, Mont. , May 28, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and wound care disorders, today announced the commercial launch of OsteoFactor Pro™, a naturally occurring cocktail of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic and spine procedures.

Prnewswire | 1 month ago
Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Brett Maas - Hayden IR Sean Browne - President and Chief Executive Officer Scott Neils - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Ryan Zimmerman - BTIG Operator Good afternoon, everyone, and welcome to the Xtant Medical's First Quarter 2025 Financial Results. At this time, all participants are in a listen-only mode, and the floor will be open for questions following the presentation.

Seekingalpha | 1 month ago
Xtant Medical Reports First Quarter 2025 Financial Results

Xtant Medical Reports First Quarter 2025 Financial Results

Revenue Increases 18% Year-over-Year Delivers Positive Net Income and $1.3 Million in Operating Cash Flow Increases 2025 Revenue Guidance to $127 Million to $131 Million BELGRADE, Mont. , May 12, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today reported financial and operating results for the first quarter ended March 31, 2025.

Prnewswire | 1 month ago

Xtant Medical Holdings Inc. Dividends

XMS is not paying dividends to its shareholders.

Xtant Medical Holdings Inc. Earnings

31 Jul 2025 (In 3 weeks) Date
-
Cons. EPS
-
EPS
13 May 2025 Date
-
Cons. EPS
0.01
EPS
31 Mar 2025 Date
-
Cons. EPS
-
EPS
7 Nov 2024 Date
-
Cons. EPS
-
EPS
8 Aug 2024 Date
-
Cons. EPS
-
EPS
XMS is not paying dividends to its shareholders.
31 Jul 2025 (In 3 weeks) Date
-
Cons. EPS
-
EPS
13 May 2025 Date
-
Cons. EPS
0.01
EPS
31 Mar 2025 Date
-
Cons. EPS
-
EPS
7 Nov 2024 Date
-
Cons. EPS
-
EPS
8 Aug 2024 Date
-
Cons. EPS
-
EPS

Xtant Medical Holdings Inc. (XMS) FAQ

What is the stock price today?

The current price is €0.60.

On which exchange is it traded?

Xtant Medical Holdings Inc. is listed on AMEX.

What is its stock symbol?

The ticker symbol is XMS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Jul 31, 2025.

Has Xtant Medical Holdings Inc. ever had a stock split?

Xtant Medical Holdings Inc. had 1 splits and the recent split was on Feb 14, 2018.

Xtant Medical Holdings Inc. Profile

Medical - Devices Industry
Healthcare Sector
Sean E. Browne CEO
XMUN Exchange
US98420P3082 ISIN
US Country
217 Employees
- Last Dividend
14 Feb 2018 Last Split
19 Oct 2015 IPO Date
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

Contact Information

Address: 664 Cruiser Lane
Phone: 406 388 0480